The DOI matches its Crossref record; 123 of the 123 references it cites were found in a registry or an index.
TREM2 — a key player in microglial biology and Alzheimer disease
Abstract
Alzheimer disease (AD) is a debilitating dementia believed to result from the deposition of extracellular amyloid-β (Aβ)-containing plaques followed by the formation of neurofibrillary tangles. Familial AD typically results from mutations in the genes encoding amyloid precursor protein (APP), presenilin 1 or presenilin 2. Variations in triggering receptor expressed on myeloid cells 2 (TREM2), one of several genes for which expression is restricted to microglia in the brain, have now been shown to increase the risk of developing late-onset AD. Microglia have been shown to respond to Aβ accumulation and neurodegenerative lesions, progressively acquiring a unique transcriptional and functional signature and evolving into disease-associated microglia (DAM). DAM attenuate the progression of neurodegeneration in certain mouse models, but inappropriate DAM activation accelerates neurodegenerative disease in other models. TREM2 is essential for maintaining microglial metabolic fitness during stress events, enabling microglial progression to a fully mature DAM profile and ultimately sustaining the microglial response to Aβ-plaque-induced pathology. Here, we review the current data detailing the role of TREM2 in microglial biology and AD.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“TREM2 engagement with ligands triggers the phosphorylation of the DAP12 ITAM, subsequently initiating a cascade of activation of downstream kinases, such as AKT, MAPK, and mTOR29,30.”
From TREM2 promotes lung fibrosis via controlling alveolar macrophage survival and pro-fibrotic activity (2025) · cites this paper as [30]
In the citing paper
“These kinases are centrally involved in controlling cell metabolism, survival, proliferation, and phagocytosis29,30.”
From TREM2 promotes lung fibrosis via controlling alveolar macrophage survival and pro-fibrotic activity (2025) · cites this paper as [30]
In the citing paper
“TREM2 engagement leads to DAP12 phosphorylation, followed by recruitment and activation of the spleen-associated tyrosine kinase (SYK), resulting in downstream signaling events leading to proliferation, survival, phagocytosis, and secretion of cytokines and chemokines [47].”
From TREM2 activation on microglia promotes myelin debris clearance and remyelination in a model of multiple sclerosis (2020) · cites this paper as [47]
In the citing paper
“The general consensus is that TREM2 is expressed by microglia in the CNS, especially after activation [6, 21, 47].”
From TREM2 activation on microglia promotes myelin debris clearance and remyelination in a model of multiple sclerosis (2020) · cites this paper as [47]
In the citing paper
“TREM2 binds on the membrane to the DNAX-activation protein 12 (DAP12) which is an adaptor protein required for TREM2 surface expression and intracellular signaling [47].”
From TREM2 activation on microglia promotes myelin debris clearance and remyelination in a model of multiple sclerosis (2020) · cites this paper as [47]
In the citing paper
“In comparison to previous studies which are aligned to the concept that suppressing microglial function may be beneficial in the setting of AD [49], the data described here, together with studies on TREM2 and other AD-associated variants, suggest that a different directionality may be therapeutically useful [6, 46, 50].”
From Alzheimer’s disease phospholipase C-gamma-2 (PLCG2) protective variant is a functional hypermorph (2019) · cites this paper as [46]
In the citing paper
“One receptor acting upstream of Plcg2 and evoking such responses in innate immune cells might be Trem2 [17, 46].”
From Alzheimer’s disease phospholipase C-gamma-2 (PLCG2) protective variant is a functional hypermorph (2019) · cites this paper as [46]
In the citing paper
“TREM2 is one of the key receptors modulating PLCγ2 activity [12, 36, 37].”
From Protective PLCG2 variants associate with a delayed onset of Alzheimer’s disease among heterozygous APOE ε4 carriers (2026) · cites this paper as [36]
In the citing paper
“Although TREM2 is expressed on the cell surface, it is cleaved from the cell surface by metalloproteases and released as soluble TREM2 (sTREM2) (Ulland and Colonna, 2018).”
From TREM2 Modulation Remodels the Tumor Myeloid Landscape Enhancing Anti-PD-1 Immunotherapy (2020) · cites this paper as Ulland and Colonna, 2018
In the citing paper
“TREM2 has been extensively studied in microglia for its capacity to sustain microglial responses to neurodegenerative pathologies such as Alzheimer’s disease (Ulland and Colonna, 2018).”
From TREM2 Modulation Remodels the Tumor Myeloid Landscape Enhancing Anti-PD-1 Immunotherapy (2020) · cites this paper as Ulland and Colonna, 2018
In the citing paper
“This could be representative of changes in TREM2 expression or shedding, both of which are altered during ageing and disease [55], thereby reducing TREM2-mediated signalling and subsequent conversion of microglia to DAM [56].”
From TREM2/PLCγ2 signalling in immune cells: function, structural insight, and potential therapeutic modulation (2021) · cites this paper as [56]
In the citing paper
“Rac is known to be activated downstream of TREM2/DAP12 via Syk and Vav2/3 activation [56].”
From TREM2/PLCγ2 signalling in immune cells: function, structural insight, and potential therapeutic modulation (2021) · cites this paper as [56]
In the citing paper
“Mutations affecting the TREM2 function impair microglial activation (37) and reduce their ability to accumulate LDs in the AD brain (38).”
From Reducing microglial lipid load enhances β amyloid phagocytosis in an Alzheimer’s disease mouse model (2025) · cites this paper as [37]
In the citing paper
“Loss-of-function (LOF) variants of TREM2, an immune receptor expressed in microglia, increase Alzheimer’s disease risk.”
From TREM2 regulates microglial cholesterol metabolism upon chronic phagocytic challenge (2020) · cites this paper as Ulland and Colonna, 2018
In the citing paper
“Certain TREM2 LOAD variants, including R47H, show reduced affinity to lipids”
From TREM2 regulates microglial cholesterol metabolism upon chronic phagocytic challenge (2020) · cites this paper as Ulland and Colonna, 2018
In the citing paper
“Most notably, a hypomorphic variant in the microglial receptor TREM2, R47H, increases the risk of AD several fold, as do other TREM2 variants, such as R62H, although with reduced penetrance14.”
From Human and mouse single-nucleus transcriptomics reveal TREM2-dependent and TREM2-independent cellular responses in Alzheimer’s disease (2020) · cites this paper as [14]
In the citing paper
“AD patients carrying the R47H variant, who have a higher risk (2-4-fold) of developing AD than do R62H carriers.”
From Human and mouse single-nucleus transcriptomics reveal TREM2-dependent and TREM2-independent cellular responses in Alzheimer’s disease (2020) · cites this paper as [14]
Citations
Cites
Corder, E. H., Saunders, A. M., Strittmatter, W. J., Schmechel, D. E., Gaskell, P. C., Small, G. W., Roses, A. D., Haines, J. L., & Pericak-Vance, M. A. (1993) · Science · doi:10.1126/science.8346443 · Cited by 9,429
A Unique Microglia Type Associated with Restricting Development of Alzheimer’s Disease
Keren-Shaul, H., Spinrad, A., Weiner, A., Matcovitch-Natan, O., Dvir-Szternfeld, R., Ulland, T. K., David, E., Baruch, K., Lara-Astaiso, D., Toth, B., et al. (2017) · Cell · doi:10.1016/j.cell.2017.05.018 · Cited by 5,493
Self-citation2016 Alzheimer's disease facts and figures
Alzheimer's Association (2016) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2016.03.001 · Cited by 5,069
Goate, A., Chartier-Harlin, M.-C., Mullan, M., Brown, J., Crawford, F., Fidani, L., Giuffra, L., Haynes, A., Irving, N., James, L., et al. (1991) · Nature · doi:10.1038/349704a0 · Cited by 4,659
Meta-Analysis of 74,046 Individuals Identifies 11 New Susceptibility Loci for Alzheimer’s Disease
(EADI), E. A. D. I., Lambert, J.-C., (GERAD), G. A. E. R. I. A. D., Alzheimer's Disease Genetic Consortium (ADGC), (CHARGE), C. F. H. A. A. R. I. G. E., Ibrahim-Verbaas, C. A., Harold, D., Naj, A. C., Sims, R., Bellenguez, C., et al. (2013) · Nature Genetics · doi:10.1038/ng.2802 · Cited by 4,336
Strittmatter, W. J., Saunders, A. M., Schmechel, D., Pericak-Vance, M., Enghild, J., Salvesen, G. S., & Roses, A. D. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.5.1977 · Cited by 4,268
Synaptic Pruning by Microglia Is Necessary for Normal Brain Development
Paolicelli, R. C., Bolasco, G., Pagani, F., Maggi, L., Scianni, M., Panzanelli, P., Giustetto, M., Ferreira, T. A., Guiducci, E., Dumas, L., et al. (2011) · Science · doi:10.1126/science.1202529 · Cited by 4,244
Microglia Sculpt Postnatal Neural Circuits in an Activity and Complement-Dependent Manner
Schafer, D. P., Lehrman, E. K., Kautzman, A. G., Koyama, R., Mardinly, A. R., Yamasaki, R., Ransohoff, R. M., Greenberg, M. E., Barres, B. A., & Stevens, B. (2012) · Neuron · doi:10.1016/j.neuron.2012.03.026 · Cited by 4,089
Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease
Sherrington, R., Rogaev, E. I., Liang, Y., Rogaeva, E. A., Levesque, G., Ikeda, M., Chi, H., Lin, C., Li, G., Holman, K., et al. (1995) · Nature · doi:10.1038/375754a0 · Cited by 4,051
Complement and microglia mediate early synapse loss in Alzheimer mouse models
Hong, S., Beja-Glasser, V. F., Nfonoyim, B. M., Frouin, A., Li, S., Ramakrishnan, S., Merry, K. M., Shi, Q., Rosenthal, A., Barres, B. A., et al. (2016) · Science · doi:10.1126/science.aad8373 · Cited by 3,343
Research works printed but not linked: 3
- Nissl, F. in Histologische und histopathologische Arbeiten über die Grosshirnrinde Vol. 1 (eds. Nissl, F., Alzheimer, A.) 315–494 (G. Fischer, Jena, Germany, 1904).
- Alzheimer, A. in Histologische und histopathologische Arbeiten über die Grosshirnrinde Vol. 3 (eds. Nissl, F., Alzheimer, A.) 401–562 (G. Fischer, Jena, Germany, 1910).
- Hortega, P. R. El tercer elemento de los centros nerviosos. III. Naturaleza probable de la microglía [Spanish]. Bol. Soc. Esp. Biol. 8, 108–115 (1919).
Cited by
Sorted by citations
Items 301–400 of 737
Lau, S., Fu, A. K. Y., & Ip, N. Y. (2023) · Journal of Neurochemistry · doi:10.1111/jnc.15933 · Cited by 21
Wang, X., Xie, Y., Fan, X., Wu, X., Wang, D., & Li, Z. (2024) · Alzheimer s Research & Therapy · doi:10.1186/s13195-024-01489-6 · Cited by 26
Impact of New Drugs for Therapeutic Intervention in Alzheimer’s Disease
Olloquequi, J., Ettcheto, M., Cano, A. C., Sánchez‐López, E., Carrasco, M., Espinosa-Jiménez, T., Beas‐Zárate, C., Gudiño‐Cabrera, G., Ureña‐Guerrero, M. E., Verdaguer, E., et al. (2022) · Frontiers in Bioscience-Landmark · doi:10.31083/j.fbl2705146 · Cited by 25
D’Oliveira Albanus, R., Finan, G. M., Brase, L., Sweeney, N., Kim, T. Y., Chen, S., Ryoo, Y., Park, J., Guo, Q., Iyer, A. K., et al. (2025) · Science Translational Medicine · doi:10.1126/scitranslmed.adx0027 · Cited by 19
Using Drosophila amyloid toxicity models to study Alzheimer's disease
Tsintzas, E., & Niccoli, T. (2024) · Annals of Human Genetics · doi:10.1111/ahg.12554 · Cited by 20
TREM2 in Neurodegenerative Diseases: Mechanisms and Therapeutic Potential
Li, L., Zheng, X., Ma, H., Zhu, M., Li, X., Sun, X., & Feng, X. (2025) · Cells · doi:10.3390/cells14171387 · Cited by 22
The evolution of microglia replacement: A new paradigm for CNS disease therapy
Rao, Y., Bai, Y., Li, X., Du, B., & Peng, B. (2025) · Cell stem cell · doi:10.1016/j.stem.2025.10.014 · Cited by 25
Bone Tissue and the Nervous System: What Do They Have in Common?
Minoia, A., Carbonare, L. D., Schwamborn, J. C., Bolognin, S., & Valenti, M. T. (2022) · Cells · doi:10.3390/cells12010051 · Cited by 19
Basha, S. C., Ramaiah, M. J., & Rao, K. S. J. (2023) · Journal of Alzheimer s Disease · doi:10.3233/jad-221070 · Cited by 23
The genetic basis of multiple system atrophy
Tseng, F. S., Foo, J. Q. X., Mai, A. S., & Tan, E. (2023) · Journal of Translational Medicine · doi:10.1186/s12967-023-03905-1 · Cited by 26
Neuroinflammation: The Abused Concept
Galea, E., & Graeber, M. B. (2023) · ASN NEURO · doi:10.1177/17590914231197523 · Cited by 21
Selection and structural characterization of anti-TREM2 scFvs that reduce levels of shed ectodomain
Szykowska, A., Chen, Y., Smith, T. B., Preger, C., Yang, J., Qian, D., Mukhopadhyay, S. M. M., Wigren, E., Neame, S. J., Gräslund, S., et al. (2021) · Structure · doi:10.1016/j.str.2021.06.010 · Cited by 20
Single-cell transcriptomics provide insight into metastasis-related subsets of breast cancer
Zhu, S., Zhang, M., Liu, X., Luo, Q., Zhou, J., Song, M., Feng, J., & Liu, J. (2023) · Breast Cancer Research · doi:10.1186/s13058-023-01728-y · Cited by 18
Function and mechanism of TREM2 in bacterial infection
Wu, Z., Yang, S., Fang, X., Shu, Q., & Chen, Q. (2024) · PLoS Pathogens · doi:10.1371/journal.ppat.1011895 · Cited by 19
TREM2 risk variants and associated endophenotypes in alzheimer’s disease
Dijkstra, J. I. R., Vermunt, L., Venkatraghavan, V., Ozhegov, G., Coomans, E. M., Ossenkoppele, R., van de Giessen, E., Hulsman, M., de Geus, C. M., van der Flier, W. M., et al. (2025) · Alzheimer's Research & Therapy · doi:10.1186/s13195-025-01700-2 · Cited by 18
Hypoxia/ischemia impairs CD33 (Siglec-3)/TREM2 signaling: Potential role in Alzheimer's pathogenesis
Salminen, A., Kaarniranta, K., & Kauppinen, A. (2021) · Neurochemistry International · doi:10.1016/j.neuint.2021.105186 · Cited by 20
The β‐adrenergic hypothesis of synaptic and microglial impairment in Alzheimer's disease
Li, S. (2023) · Journal of Neurochemistry · doi:10.1111/jnc.15782 · Cited by 18
Immune response of BV-2 microglial cells is impacted by peroxisomal beta-oxidation
Tawbeh, A., Raas, Q., Tahri-Joutey, M., Keime, C., Kaiser, R., Trompier, D., Nasser, B., Bellanger, E., Dessard, M., Hamon, Y., et al. (2023) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2023.1299314 · Cited by 18
Adrenal gland macrophages regulate glucocorticoid production through Trem2 and TGF-β
Xu, Y., Patterson, M. T., Dolfi, B., Zhu, A., Bertola, A., Schrank, P. R., Gallerand, A., Kennedy, A. E., Hillman, H., Dinh, L., et al. (2024) · JCI Insight · doi:10.1172/jci.insight.174746 · Cited by 20
The Role of TREML2 in Alzheimer’s Disease
Wang, S., Gong, P., Yan, E., Zhang, Y., & Jiang, T. (2020) · Journal of Alzheimer s Disease · doi:10.3233/jad-200406 · Cited by 18
The search for Alzheimer disease therapeutics — same targets, better trials?
Rafii, M. S., & Aisen, P. S. S. (2020) · Nature Reviews Neurology · doi:10.1038/s41582-020-00414-3 · Cited by 19
The Role of Microglia in Inherited White-Matter Disorders and Connections to Frontotemporal Dementia
Sirkis, D. W., Bonham, L. W., & Yokoyama, J. S. (2021) · The Application of Clinical Genetics · doi:10.2147/tacg.s245029 · Cited by 21
Advances in Genetic and Molecular Understanding of Alzheimer’s Disease
Ibáñez, L., Cruchaga, C., & Fernández, M. V. (2021) · Genes · doi:10.3390/genes12081247 · Cited by 20
ApoE: The Non-Protagonist Actor in Neurological Diseases
Grimaldi, L., Bovi, E., Formisano, R., & Sancesario, G. M. (2024) · Genes · doi:10.3390/genes15111397 · Cited by 18
Unraveling the Immune Puzzle: Role of Immunomodulation in Alzheimer’s Disease
Ashvin, Dhapola, R., Kumari, S., Sharma, P., Vellingiri, B., Medhi, B., & HariKrishnaReddy, D. (2025) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-025-10210-9 · Cited by 19
As48, a first-in-class dual-function TREM2 modulator: Receptor activation and shedding inhibition
Cho, S., Gaamouch, F. E., Upadhyay, S., Nada, H., Kuncewicz, K., & Gabr, M. T. (2025) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2025.118862 · Cited by 15
Pan, J., Sun, D., Lee, D., Xiong, L., Ren, X., Guo, H.-H., Yao, L., Lu, Y., Jung, C., & Xiong, W. (2021) · Communications Biology · doi:10.1038/s42003-021-02843-2 · Cited by 17
Liu, C., Shan, F., Gao, F., Ji, Q., Chen, Y., Wang, C., Wang, Z., Gao, P., Lv, Z., & Wang, Y. (2022) · Experimental Neurology · doi:10.1016/j.expneurol.2022.114296 · Cited by 17
Cerebral amyloid angiopathy and the immune system
Munsterman, D., Falcione, S. R., Long, R., Boghozian, R., Joy, T., Camicioli, R. M., Smith, E. E., & Jickling, G. C. (2024) · Alzheimer s & Dementia · doi:10.1002/alz.13826 · Cited by 16
Trem2 acts as a non‐classical receptor of interleukin‐4 to promote diabetic wound healing
Zhu, X., Zhang, C., Jiang, W., Zeng, Z., Zhang, K., Du, M., Chen, J., Wu, Q., Liao, W., Chen, Y., et al. (2024) · Clinical and Translational Medicine · doi:10.1002/ctm2.70026 · Cited by 17
Microglia Process α‐Synuclein Fibrils and Enhance their Pathogenicity in a TREM2‐Dependent Manner
Xiong, M., Xia, D., Yu, H., Meng, L., Zhang, X., Chen, J., Tian, Y., Yuan, X., Niu, X., Nie, S., et al. (2024) · Advanced Science · doi:10.1002/advs.202413451 · Cited by 21
Honig, M. G., Mar, N. A. D., Henderson, D. L., O’Neal, D., Doty, J. B., Cox, R., Li, C., Perry, A. M., Moore, B. M., II, & Reiner, A. J. (2021) · Frontiers in Neuroscience · doi:10.3389/fnins.2021.701317 · Cited by 16
Peroxisomal defects in microglial cells induce a disease-associated microglial signature
Raas, Q., Tawbeh, A., Tahri-Joutey, M., Gondcaille, C., Keime, C., Kaiser, R., Trompier, D., Nasser, B., Leoni, V., Bellanger, E., et al. (2023) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2023.1170313 · Cited by 16
Ren, J., Xiang, B., Xueling, L., Han, X., Yang, Z., Zhang, M., & Zhang, Y. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e36470 · Cited by 16
Pathogenesis and therapeutic applications of microglia receptors in Alzheimer’s disease
Fu, J., Wang, R., He, J., Liu, X., Wang, X., Yao, J., Liu, Y., Ran, C., Ye, Q., & He, Y. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1508023 · Cited by 17
Macrophages: sentinels, warriors, and healers
Bernier, E., Bartnicki, E., & Khanna, K. M. (2025) · Human Molecular Genetics · doi:10.1093/hmg/ddaf087 · Cited by 17
Yuan, S., Gaamouch, F. E., Cho, S., Kuncewicz, K., Nada, H., & Gabr, M. T. (2025) · ACS Medicinal Chemistry Letters · doi:10.1021/acsmedchemlett.5c00299 · Cited by 17
Engineered Stem Cell Membrane-Coated Nanodrugs for Targeted Therapy of Alzheimer’s Disease
Sha, S., Sun, C., Gao, X., Bi, W., Chen, H., Ren, W., Wang, L., Luo, E., Xing, C., & Du, H. (2025) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.5c09843 · Cited by 17
Tavares-Gomes, L., Monney, C., Neuhaus, G., Francisco, D. M. F., Solis, D., Summerfield, A., Erny, D., Jagannathan, V., & Oevermann, A. (2021) · Glia · doi:10.1002/glia.24002 · Cited by 17
Wieczorek, K., Markiewicz, M., Walczewska, A., & Zgórzyńska, E. (2023) · Cellular Physiology and Biochemistry · doi:10.33594/000000668 · Cited by 16
The role of microglial TREM2 in development: A path toward neurodegeneration?
Matteoli, M. (2024) · Glia · doi:10.1002/glia.24574 · Cited by 16
Role of triggering receptor expressed on myeloid cells 2 (TREM2) in neurodegenerative dementias
Shafi, S., Singh, A., Ibrahim, A. M., Alhajri, N., Izneid, T. A., & Pottoo, F. H. (2021) · European Journal of Neuroscience · doi:10.1111/ejn.15215 · Cited by 15
Han, S., Na, Y., Koh, I., Nho, K. T., & Lee, Y. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22189865 · Cited by 16
Lu, Y., Xu, K., Lin, D., Wang, S., Fu, R., Deng, X., Croppi, G., & Zhang, J. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.964429 · Cited by 18
Pankiewicz, J. E., Lizińczyk, A. M., Franco, L. A., Diaz, J. R., Martá-Ariza, M., & Sadowski, M. J. (2021) · Acta Neuropathologica Communications · doi:10.1186/s40478-021-01261-z · Cited by 15
Jiang, L., Roberts, R., Wong, M., Zhang, L., Webber, C. J., Libera, J., Wang, Z., Kilci, A., Jenkins, M., Ortiz, A. R., et al. (2024) · Frontiers in Neuroscience · doi:10.3389/fnins.2024.1372297 · Cited by 15
Takata, M., Nishimura, K., Harada, K., Iwasaki, R., Ando, M., Yamada, S., Ginhoux, F., & Takata, K. (2023) · Tissue and Cell · doi:10.1016/j.tice.2023.102023 · Cited by 15
ApoE4 makes microglia trem2bling
Heneka, M. T. (2023) · Neuron · doi:10.1016/j.neuron.2022.12.032 · Cited by 15
Kong, S., Wen, X., Wang, Y., Tan, R., Li, H., & Tu, Y. (2023) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.3c00568 · Cited by 15
Glycoprotein Non-Metastatic Protein B (GPNMB): The Missing Link Between Lysosomes and Obesity
Bianco, V., & Kratky, D. (2023) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/a-2192-0101 · Cited by 17
He, Z., Chen, Q., Wang, K., Lin, J., Peng, Y., Zhang, J., Yan, X., & Yan, J. (2024) · European Journal of Neuroscience · doi:10.1111/ejn.16242 · Cited by 18
Liu, L., Liang, J., Liu, Y.-H., Liu, B., Dong, X., Cai, W.-H., & Zhang, N. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e30523 · Cited by 15
RetractedEmerging microglial biology highlights potential therapeutic targets for Alzheimer's disease
Fan, X., Chen, H., He, W., & Zhang, J. (2024) · Ageing Research Reviews · doi:10.1016/j.arr.2024.102471 · Cited by 16
Milazzo, R., Montepeloso, A., Kumar, R., Ferro, F., Cavalca, E., Rigoni, P., Cabras, P., Ciervo, Y., Das, S., Capotondo, A., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-52301-w · Cited by 18
Navigating the Alzheimer’s Biomarker Landscape: A Comprehensive Analysis of Fluid-Based Diagnostics
Abiad, E. E., Al-Kuwari, A., Al-Aani, U., Jaidah, Y. A., & Châari, A. (2024) · Cells · doi:10.3390/cells13221901 · Cited by 17
Microglial Modulation in Alzheimer’s Disease: Central Players in Neuroinflammation and Pathogenesis
Hussain, M. S., Khan, Y., Fatima, R., Maqbool, M., Ramalingam, P. S., Khan, M. G., & Bisht, A. S. (2025) · Current Alzheimer Research · doi:10.2174/0115672050364292250113063513 · Cited by 15
Xu, D., Yu, Y., Xu, Y., & Ge, J. (2021) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s323009 · Cited by 15
García, F., & Heiman, M. (2025) · Molecular Neurodegeneration · doi:10.1186/s13024-025-00799-z · Cited by 14
Ke, J., Ding, J., Xu, Y., Yu, C., Hong, Y., Li, S., Meng, T., Yuan, P., Yuan, H., & Hu, F. (2025) · Biomaterials Science · doi:10.1039/d5bm01080b · Cited by 17
Wang, Z., Sun, Y., Ma, Y., Fu, Y., Hu, H., Xu, W., Wang, Z.-T., Ma, L., Tan, L., & Yu, J. (2022) · Translational Psychiatry · doi:10.1038/s41398-022-01910-4 · Cited by 15
Neuroimmunomodulatory properties of polysialic acid
Gretenkort, L., Thiesler, H., & Hildebrandt, H. (2023) · Glycoconjugate Journal · doi:10.1007/s10719-023-10120-z · Cited by 16
TREM2 as an evolving therapeutic target in Alzheimer’s disease
George, J. (2023) · Neural Regeneration Research · doi:10.4103/1673-5374.371360 · Cited by 14
Yassaghi, Y., Nazerian, Y., Ghasemi, M., Nazerian, A., Sayehmiri, F., Perry, G. L., & Pourbadie, H. G. (2024) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.18554 · Cited by 15
Farzan, M., Rounkian, M. S., Rizi, A. A., Heidari, Z., Farzan, M., Fathi, M., Aghaei, A., Azadegan‐Dehkordi, F., & Bagheri, N. (2024) · Experimental Neurology · doi:10.1016/j.expneurol.2024.115071 · Cited by 15
Vasilopoulou, F., Piers, T. M., Wei, J., Hardy, J., & Pocock, J. M. (2024) · FEBS Journal · doi:10.1111/febs.17353 · Cited by 17
The multicellular interplay of microglia in health and disease: lessons from leukodystrophy
Berdowski, W. M., Sanderson, L. E., & van Ham, T. J. (2021) · Disease Models & Mechanisms · doi:10.1242/dmm.048925 · Cited by 15
Toledano, R. S., & Akirav, I. (2025) · Neuropsychopharmacology · doi:10.1038/s41386-025-02213-0 · Cited by 17
Zhang, Z., Yu, K., Cao, Y., Xie, P., Wang, L., Shen, Z., & Qin, J. (2025) · Cell Death and Disease · doi:10.1038/s41419-025-08198-4 · Cited by 19
Hu, L., Chen, Z., Lu, J., Jiang, S., Lin, H., Zhou, J., Wang, N., Ding, C., Ni, W., Peng, H., et al. (2025) · Journal of Extracellular Vesicles · doi:10.1002/jev2.70041 · Cited by 16
Jiahuan, X., Ying, Z., Hongyu, J., Wei, Z., Guan, S., Chengyue, D., Liangyu, F., Fan, L., & Wang, W. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.843828 · Cited by 13
Lack of association between TREM2 rs75932628 variant and amyotrophic lateral sclerosis
Siokas, V., Aloizou, A., Liampas, I., Tsouris, Z., Mentis, A. A., Nasios, G., Papadimitriou, D. A., Bogdanos, D. P., Hadjigeorgiou, G. M., & Dardiotis, E. (2021) · Molecular Biology Reports · doi:10.1007/s11033-021-06312-1 · Cited by 13
An Integrated Molecular Atlas of Alzheimer’s DiseasePreprint
Wörheide, M. A., Krumsiek, J., Nataf, S., Nho, K. T., Greenwood, A. K., Wiley, J. C., Willruth, L.-L., Wu, T., Bellur, O., Marella, B., et al. (2021) · medRxiv · doi:10.1101/2021.09.14.21263565 · Cited by 12
Nada, H., Yuan, S., Gaamouch, F. E., Cho, S. W., Kuncewicz, K., Calvo‐Barreiro, L., & Gabr, M. T. (2025) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2025.118358 · Cited by 11
Tanaka, M., Yamakage, H., Muranaka, K., Yamada, T., Araki, R., Ogo, A., Matoba, Y., Watanabe, T., Saito, M. H., Kurita, S., et al. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.880148 · Cited by 13
Ji, P., Chen, Y., Ni, X., Miao, Q., & Hua, J. (2023) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.16417 · Cited by 12
Deferoxamine Induces Autophagy Following Traumatic Brain Injury via TREM2 on Microglia
Zhang, C., Chen, X., Yao, J., Cao, H., Wang, X., Zhao, J., Gong, Q., & Chen, S. (2023) · Molecular Neurobiology · doi:10.1007/s12035-023-03875-x · Cited by 12
Shen, Z., Yang, X., Lan, Y., & Chen, G. (2024) · Journal of Alzheimer s Disease · doi:10.3233/jad-231159 · Cited by 13
The longitudinal trajectory of CSF sTREM2: the alzheimer’s disease neuroimaging initiative
Wang, Y. T., Ye, M., Ji, Q., Liu, Q., Xu, X., & Zhan, Y. (2024) · Alzheimer s Research & Therapy · doi:10.1186/s13195-024-01506-8 · Cited by 13
Tissue‐Resident Macrophages in Cancer: Friend or Foe?
Chi, J., Gao, Q., & Liu, D. (2024) · Cancer Medicine · doi:10.1002/cam4.70387 · Cited by 13
Chen, Q., Yang, Y., Wu, X., Yang, S., Zhang, Y., Shu, Q., & Fang, X. (2020) · Shock · doi:10.1097/shk.0000000000001668 · Cited by 13
The Strategies for Treating “Alzheimer’s Disease”: Insulin Signaling May Be a Feasible Target
You, G., Yao, J., Liu, Q., & Li, N. (2022) · Current Issues in Molecular Biology · doi:10.3390/cimb44120421 · Cited by 12
How Microglia Manages Non-cell Autonomous Vicious Cycling of Aβ Toxicity in the Pathogenesis of AD
Seol, Y., Ki, S., Ryu, H. L., Chung, S., Lee, J.-H., & Ryu, H. (2020) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2020.593724 · Cited by 12
Microglia at the Centre of Brain Research: Accomplishments and Challenges for the Future
Soares, N. L., & Vieira, H. L. A. (2021) · Neurochemical Research · doi:10.1007/s11064-021-03456-1 · Cited by 14
Galizzi, G., Deidda, I., Amato, A., Calvi, P., Terzo, S., Caruana, L., Scoglio, S., Mulè, F., & Carlo, M. D. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24054731 · Cited by 14
Ma, W., Zhao, L., Xu, B., Fariss, R. N., Redmond, T. M., Zou, J., Wong, W. T., & Li, W. (2023) · eLife · doi:10.7554/elife.90695.3 · Cited by 14
Cho, S., Szalai, T. V., Gaamouch, F. E., Bajusz, D., Keserű, G. M., & Gabr, M. T. (2026) · ACS Medicinal Chemistry Letters · doi:10.1021/acsmedchemlett.5c00542 · Cited by 12
Milos, T., Vuić, B., Balic, N., Farkaš, V., Erjavec, G. N., Štrac, D. Š., Perković, M. N., & Pivac, N. (2024) · Expert Review of Neurotherapeutics · doi:10.1080/14737175.2024.2400683 · Cited by 11
Perdaens, O., & Pesch, V. V. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252312637 · Cited by 12
Neuroglia in Neurodegeneration: Exploring Glial Dynamics in Brain Disorders
Dar, N. J., Bhat, J. A., John, U., & Bhat, S. A. (2024) · Neuroglia · doi:10.3390/neuroglia5040031 · Cited by 14
Datta, D., & Arnsten, A. F. T. (2025) · Alzheimer s & Dementia · doi:10.1002/alz.14477 · Cited by 11
Giorgio, J., Jonson, C., Wang, Y., Yokoyama, J. S., Wang, J., Jagust, W. J., & Initiative, O. B. O. T. A. D. N. (2025) · Nature Communications · doi:10.1038/s41467-025-60370-8 · Cited by 14
Vogrinc, D., Goričar, K., Kunej, T., & Dolžan, V. (2021) · Journal of Personalized Medicine · doi:10.3390/jpm11100946 · Cited by 11
Activation of the hypoxia response protects mice from amyloid-β accumulation
Ollonen, T., Kurkela, M., Laitakari, A., Sakko, S., Koivisto, H., Myllyharju, J., Tanila, H., Serpi, R., & Koivunen, P. (2022) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-022-04460-6 · Cited by 11
Shallie, O. F., & Mabandla, M. V. (2020) · Behavioural Brain Research · doi:10.1016/j.bbr.2020.112795 · Cited by 12
Role of TREM2 in neuroinflammation
Abdulkhaliq, A. A., Alasiri, G. A., Almoghrabi, Y. M., Kim, B., Khan, J., Ajoolabady, A., Ren, J. T., Tuomilehto, J. O., Borai, A., & Praticò, D. (2025) · Experimental Neurology · doi:10.1016/j.expneurol.2025.115547 · Cited by 10
Cho, S., Kaur, B., Lam, K., Gaamouch, F. E., Kuncewicz, K., Doering, N. P., Wolber, G., & Gabr, M. T. (2026) · ChemMedChem · doi:10.1002/cmdc.202500718 · Cited by 8
Behroozi, Z., Askarpour, H., & Baghcheghi, Y. (2026) · Journal of Alzheimer s Disease Reports · doi:10.1177/25424823261415807 · Cited by 10
Lipid-associated macrophages and metabolic inflammatory diseases
Zheng, Y., Tu, D., Dong, C., Zhao, H., & Wang, H. (2026) · Cell Insight · doi:10.1016/j.cellin.2026.100312 · Cited by 12
Metabolic and inflammatory roles of glial cells in neurodegenerative and cerebrovascular diseases
OGUNLEYE, F. A., Zhou, Y., Yan, L., Abhulimen, P. O., Xu, Y., Lai, M. K. P., Okunowo, W. O., Sethi, G., Fang, C., & Ma, Y. (2026) · Ageing Research Reviews · doi:10.1016/j.arr.2026.103120 · Cited by 11
What Is the Role of Microglial Metabolism in Inflammation and Neurodegeneration?
Benarroch, E. E. (2022) · Neurology · doi:10.1212/wnl.0000000000200920 · Cited by 10
Metadata
- Authors
- Ulland, T. K., & Colonna, M.
- Affiliations
- University of Wisconsin–Madison (US)
- Washington University in St. Louis (US)
- Corresponding author
- Colonna, Marco
- Venue
- Nature Reviews Neurology
- Published
- 2018-09-28
- Volume
- 14
- Issue
- 11
- Pages
- 667-675
- ISSN
- 1759-4758 (ISSN-L)
- 1759-4766
- OpenAlex
- W2894203109
- Semantic Scholar
- ee2227720d29d3e454a2aa0cfa8d9df4c32b869a
- Cited by
- 735
- References
- 123
- Citations by year
- 2026: 102 · 2025: 115 · 2024: 119 · 2023: 100 · 2022: 117 · 2021: 89 · 2020: 60 · 2019: 29 · 2018: 3
- FWCI
- 4.28
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Reviews Neurology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Inflammasome and immune disorders
- Keywords
- TREM2, Alzheimer's disease, microglia, disease-associated microglia, amyloid plaques, neuroinflammation, late-onset Alzheimer's disease, neurodegeneration
- MeSH terms
- Alzheimer Disease, Animals, Humans, Membrane Glycoproteins, Mutation, Receptors, Immunologic, Amyloid beta-Protein Precursor, Microglia, Presenilins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
